RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Amylyx Pharmaceuticals Stock

Amylyx Pharmaceuticals Revenue 2024

Amylyx Pharmaceuticals Revenue

89.36 M USD

Ticker

AMLX

ISIN

US03237H1014

In 2024, Amylyx Pharmaceuticals's sales reached 89.36 M USD, a -76.53% difference from the 380.79 M USD sales recorded in the previous year.

The Amylyx Pharmaceuticals Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2029e20.411741,12
2028e9.793630,41
2027e3.4210405,42
2026e259.75136,80
2025e222.95159,38
2024e89.36397,65
2023380.7993,32
202222.2386,55
20210.29122532,76
20200.6554668,46
20191.4324849,30

Amylyx Pharmaceuticals Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Amylyx Pharmaceuticals, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Amylyx Pharmaceuticals from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Amylyx Pharmaceuticals’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Amylyx Pharmaceuticals. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Amylyx Pharmaceuticals’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Amylyx Pharmaceuticals’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Amylyx Pharmaceuticals’s growth potential.

Amylyx Pharmaceuticals Revenue, EBIT and net profit per share

DateAmylyx Pharmaceuticals RevenueAmylyx Pharmaceuticals EBITAmylyx Pharmaceuticals Net Income
2029e20.41 M undefined0 undefined-45.83 M undefined
2028e9.79 M undefined-56.96 M undefined-56.25 M undefined
2027e3.42 M undefined-72.81 M undefined-69.44 M undefined
2026e259.75 M undefined-138.04 M undefined-114.58 M undefined
2025e222.95 M undefined-148.97 M undefined-132.91 M undefined
2024e89.36 M undefined-250.78 M undefined-286.62 M undefined
2023380.79 M undefined38.8 M undefined49.27 M undefined
202222.23 M undefined-201.34 M undefined-198.38 M undefined
2021290,000 undefined-82.69 M undefined-87.93 M undefined
2020650,000 undefined-39.01 M undefined-42.28 M undefined
20191.43 M undefined-13.55 M undefined-13.72 M undefined

Amylyx Pharmaceuticals stock margins

The Amylyx Pharmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Amylyx Pharmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Amylyx Pharmaceuticals.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Amylyx Pharmaceuticals's sales revenue. A higher gross margin percentage indicates that the Amylyx Pharmaceuticals retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Amylyx Pharmaceuticals's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Amylyx Pharmaceuticals's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Amylyx Pharmaceuticals's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Amylyx Pharmaceuticals. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Amylyx Pharmaceuticals's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Amylyx Pharmaceuticals Margin History

Amylyx Pharmaceuticals Gross marginAmylyx Pharmaceuticals Profit marginAmylyx Pharmaceuticals EBIT marginAmylyx Pharmaceuticals Profit margin
2029e93.32 %0 %-224.56 %
2028e93.32 %-581.99 %-574.66 %
2027e93.32 %-2,132.04 %-2,033.43 %
2026e93.32 %-53.14 %-44.11 %
2025e93.32 %-66.82 %-59.61 %
2024e93.32 %-280.64 %-320.74 %
202393.32 %10.19 %12.94 %
202286.55 %-905.71 %-892.4 %
202193.32 %-28,513.79 %-30,320.69 %
202093.32 %-6,001.54 %-6,504.62 %
201993.32 %-947.55 %-959.44 %

Amylyx Pharmaceuticals Aktienanalyse

What does Amylyx Pharmaceuticals do?

Amylyx Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Amylyx Pharmaceuticals's Sales Figures

The sales figures of Amylyx Pharmaceuticals originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Amylyx Pharmaceuticals’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Amylyx Pharmaceuticals's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Amylyx Pharmaceuticals’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Amylyx Pharmaceuticals stock

How much revenue did Amylyx Pharmaceuticals generate this year?

Amylyx Pharmaceuticals has achieved a revenue of 89.36 M USD this year.

How much was the turnover of the company Amylyx Pharmaceuticals compared to the previous year?

The revenue of Amylyx Pharmaceuticals has increased by -76.53% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Amylyx Pharmaceuticals?

The revenue of Amylyx Pharmaceuticals is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Amylyx Pharmaceuticals measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Amylyx Pharmaceuticals so important for investors?

The revenue of Amylyx Pharmaceuticals is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Amylyx Pharmaceuticals pay?

Over the past 12 months, Amylyx Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Amylyx Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Amylyx Pharmaceuticals?

The current dividend yield of Amylyx Pharmaceuticals is .

When does Amylyx Pharmaceuticals pay dividends?

Amylyx Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Amylyx Pharmaceuticals?

Amylyx Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Amylyx Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Amylyx Pharmaceuticals located?

Amylyx Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Amylyx Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Amylyx Pharmaceuticals from 9/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.

When did Amylyx Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of Amylyx Pharmaceuticals in the year 2023?

In the year 2023, Amylyx Pharmaceuticals distributed 0 USD as dividends.

In which currency does Amylyx Pharmaceuticals pay out the dividend?

The dividends of Amylyx Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Amylyx Pharmaceuticals

Our stock analysis for Amylyx Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amylyx Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.